Koers Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Aandelen
688192
CNE1000055W8
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
44,39 CNY | +3,26% | +19,49% | -7,23% |
Omzet 2023 | 91,29 mln. 12,6 mln. 11,74 mln. | Omzet 2024 * | 490 mln. 67,62 mln. 63,04 mln. | Marktkapitalisatie | 17,87 mld. 2,47 mld. 2,3 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -1,12 mld. -155 mln. -144 mln. | Nettowinst (verlies) 2024 * | -649 mln. -89,57 mln. -83,5 mln. | EV/omzet 2023 | 214 x |
Nettoliquiditeiten 2023 * | - 0 0 | Nettoliquiditeiten 2024 * | - 0 0 | EV/omzet 2024 * | 36,5 x |
K/w-verhouding 2023 |
-17,4
x | K/w-verhouding 2024 * |
-27,6
x | Werknemers | 424 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 18,48% |
1 dag | +1,92% | ||
1 week | +15,72% | ||
Lopende maand | -4,45% | ||
1 maand | +1,01% | ||
3 maanden | +14,18% | ||
6 maanden | +24,18% | ||
Lopend jaar | -10,16% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Xiao Lin Zhang
CEO | Chief Executive Officer | 60 | 27-10-17 |
Wei Wen Dong
CHM | Chairman | 38 | 01-06-18 |
Hong Bin Lu
DFI | Director of Finance/CFO | 46 | 01-07-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Simon Lü
BRD | Director/Board Member | 56 | 01-10-17 |
Xue Gong Wang
BRD | Director/Board Member | 52 | 07-09-20 |
Guan Shan Zhu
BRD | Director/Board Member | 60 | 08-09-20 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 44,39 | +3,26% | 2 087 549 |
25-04-24 | 42,99 | +1,92% | 2 988 799 |
24-04-24 | 42,18 | +0,86% | 2 589 122 |
23-04-24 | 41,82 | +10,99% | 3 851 922 |
22-04-24 | 37,68 | +6,44% | 2 325 619 |
slotkoers Shanghai S.E., 25 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-10,16% | 2,47 mld. | |
-2,26% | 103 mld. | |
+1,41% | 95,71 mld. | |
+0,70% | 22,02 mld. | |
-17,84% | 20,9 mld. | |
-9,33% | 17,85 mld. | |
-42,83% | 16,21 mld. | |
-17,63% | 15,52 mld. | |
+4,55% | 13,86 mld. | |
+32,11% | 12,04 mld. |